Henlius Gets Fourth Chinese Biosimilar With Bevacizumab Nod

Cites ‘Huge Demand’ For Avastin Rival In China; Also Developing Ophthalmic Version

 
• By David Wallace
Four Thumbs Up Icons Yellow
The NMPA nod marks Henlius’ fourth Chinese biosimilar approval • Source: Alamy

More from Biosimilars

More from Products